Comparison of quality of facial scars after single low-level laser therapy and combined low-level with high-level (PDL 595 nm) laser therapy

2015 ◽  
Vol 28 (4) ◽  
pp. 201-209 ◽  
Author(s):  
Jana Vranova ◽  
Eva Remlova ◽  
Helena Jelinkova ◽  
Jozef Rosina ◽  
Tatjana Dostalova
2013 ◽  
Vol 19 (3) ◽  
pp. 195 ◽  
Author(s):  
SenthilP Kumar ◽  
Krishna Prasad ◽  
Kamalaksha Shenoy ◽  
Mariella D′Souza ◽  
VijayaK Kumar

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Loris Barale ◽  
Paolo Monticelli ◽  
Massimo Raviola ◽  
Chiara Adami

Background: Osteoarthritis (OA) is common in dogs and causes chronic pain that affects the quality of life and may not respond to analgesics.Objective: The objective of this study was to determine whether low-level laser therapy (LLLT) would improve the quality of life and help reducing systemic analgesics, in dogs with OA.Methods: Seventeen client-owned dogs diagnosed with OA and associated pain were included. The diagnosis of OA was confirmed by orthopedic and radiographic examination. Pain was evaluated in each dog with the canine brief pain inventory (CBPI), compiled by the dog owners, as well as with a visual analog scale (VAS) and the colorado state canine chronic pain scale, used by the clinician. The LLLT was performed weekly in each study dog, for a total period of 6 weeks. The CBPI was then repeated at 2, 4, 6, and 8 weeks after the first laser session, whereas the VAS was reassessed at weeks 2 and 6. The dogs were observed for the occurrence of laser-related side effects.Results: Both CBPI and VAS were significantly reduced after the first laser session (9.2 ± 3.8 and 5.2 ± 1.1, respectively) compared to pretreatment values (11.8 ± 3.6 and 7.6 ± 0.9, respectively; and p = 0.018 and p < 0.001, respectively) and continued to decrease over time until the end of the therapy. Based on these results and improved function, as assessed by the orthopedic surgeon, the pharmacological analgesic therapy was reduced by the clinician at week 2 in 13 of 17 dogs. Laser-related side effects were not observed.Conclusion: This retrospective report provides a basis for future investigations, needed to clarify whether laser therapy may be beneficial to treat canine OA-associated pain. The preliminary findings are promising and suggest that LLLT may help reducing the analgesic administration and improving client satisfaction and the quality of life of dogs with OA. Keywords: Canine osteoarthritis, Chronic pain, Low-intensity laser therapy, Orthopedic pain.


2014 ◽  
Vol 32 (6) ◽  
pp. 315-321 ◽  
Author(s):  
Farzad Fazilat ◽  
Mahdi Ghoreishian ◽  
Reza Fekrazad ◽  
Katayoun A. M. Kalhori ◽  
Sara Dehghan Khalili ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-13 ◽  
Author(s):  
Gang-Zhu Xu ◽  
Jie Jia ◽  
Lin Jin ◽  
Jia-Heng Li ◽  
Zhan-Yue Wang ◽  
...  

Objectives. We systematically reviewed randomized controlled trials (RCTs) of the effect of low-level laser therapy (LLLT) versus placebo in patients with temporomandibular disorder (TMD). Methods. A systematic search of multiple online sources electronic databases was undertaken. The methodological quality of each included study was assessed using the modified Jadad scale, and the quality of evidence was evaluated using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. Results. A total of 31 RCTs were included. Total modified Jadad scale scores showed that the methodological quality was high in 30 studies and low in 1 study. Combining data from all clinically heterogeneous studies revealed positive effects of LLLT on pain relief, regardless of the visual analogue scale (VAS) score or the change of VAS score between the baseline and the final follow-up time point, while dosage analyses showed discrepant results about the effects of high or low doses for patients with TMD. Follow-up analyses showed that LLLT significantly reduced pain at the short-term follow-up. Temporomandibular joint function outcomes indicated that the overall effect favored LLLT over placebo. Conclusion. This systematic review suggests that LLLT effectively relieves pain and improves functional outcomes in patients with TMD.


2020 ◽  
Vol 7 (9) ◽  
pp. 3971-3976
Author(s):  
Türkan Turgay ◽  
Tuba Denkçeken

Introduction: In this study, the aim was to evaluate the effect of low-level laser therapy (LLLT) on quality of life in postmastectomy lymphedema (PML) patients. Methods: Twenty-four female patients diagnosed with PML were included in the study. Demographic features, disease and lymphedema duration, cancer type, cancer stage, operation type, radiotherapy and chemotherapy history, lymphedematous and dominant extremity, and body mass index (BMI) were recorded. LLLT was applied to the affected limb as 904 nm, 1.5 Joule/cm2, three days a week for a total of 8 weeks. Quality of life assessment, lymphedema severity, and lymphedema staging was performed to measure effectiveness before and after treatment. Patients with lymphedema not associated with breast cancer and/or primary lymphedema, ongoing radiotherapy, metastatic high-grade breast cancer, acute infection, and deep vein thrombosis were excluded from the study. Results: Modified radical mastectomy was reported in 18 patients; total mastectomy and sentinel lymph node biopsy were reported in 6 patients. Of the patients, 45.8% were stage 3, and 54.2% were stage 2. Of the patients, 95.8% had a history of chemotherapy and 83% of radiotherapy after surgery. In this study, following LLLT, improvement of lymphedema stage and severity were found to be statistically significant (p < 0.05). In the evaluation of lymphedema quality of life, there was a statistically significant improvement in parameters including function, appearance, clinical symptoms, and overall quality of life (p < 0.05). However, no improvement was observed in the emotional state parameter (p > 0.05).  Conclusion: Thus, LLLT is a safe treatment method that increases the quality of life in breast cancerrelated lymphedema patients.


1970 ◽  
Vol 5 (01) ◽  
pp. 1-10
Author(s):  
Andi Dala Intan ◽  
Nyoman Murdana ◽  
SA Nuhonni ◽  
Lilies Dwi

Background: Low-Level Laser Therapy (LLLT) is a physical modality used in a rehabilitation support service. Patients with lower third molar impacted experience decline in QOL due to inflamatory response,such as bleeding, swelling, stiffness and pain. This leads to disability in daily activities, such as eating and drinking during several days post removal.Methods: It is a randomized controlled trial (RCT) and single blind study. A total of 21 subjects in LLLT and 21 subjects in control groups with the age range of 18-30 years. Subjects in the study group were given a totaldose of 54 J, energy density 18J/cm2 on day 0, 3 and 7 post lower third molar impacted surgery. Both groups were assessed for QOL values using the Short Form 36 (SF-36) before and after therapy.Result: Decrease in Pain (VAS) and Trismus on the third and seventh day post operatively were statistically significant (p <0.05) between the two groups. QOL improvement on the SF-36 domains of Role Physically(RP), Bodily Pain (BP), General Health (GH) was statistically significant (p <0.05) in both groups. Moreover, QOL improvement in Physical Components (PCS) was also significant between the two groups.Conclusion: LLLT could reduce postoperative pain of lower third molar impacted patients from day 0 to 3 and completely painless on the seventh day postoperatively. LLLT therapy eliminated Trismus on the third dayafter the surgey. Increase QOL in patients with lower third molar impacted removal after LLLT was evident in the physical component. The positive changes in pain and trismus reduction, also QOL improvement postLLLT can restore patients’ activities of daily living as usual in a short period of time.Keywords : Low Level Laser Therapy (LLLT), Pain, Trismus, Quality of Life, Rehabilitation, Lower Third Molar Removal.


Sign in / Sign up

Export Citation Format

Share Document